SAN DIEGO--(BUSINESS WIRE)--Aethlon Medical, Inc. (OTCBB:AEMD) disclosed today that a peer reviewed scientific paper coauthored by Aethlon researchers has been published in the Journal of Translational Medicine. The paper entitled, “Exosomes as a Tumor Immune Escape Mechanism: Possible Therapeutic Implications” discusses the mechanism by which exosomes released by cancerous tumors are able to kill off immune cells in cancer patients. The paper further discusses the novel therapeutic approach of the Aethlon Hemopurifier® to capture and inhibit the spread of such immunosuppressive exosomes in cancer patients. The abstract and complete article are available to be accessed online at: www.translational-medicine.com/content/6/1/37.
